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Relationship of coronary risk factors to hemodialysis-associated ische-
mic heart disease. The records of 320 hemodialysis patients at risk for
developing ischemic heart disease (IHD) were examined to determine
the influence of the established risk factors of blood pressure, smoking,
serum triglycerides, and age on the incidence of IHD and to develop
coronary risk profiles for the hemodialysis population. The role of
packed red blood cell volume, race, sex, and cause of renal failure on
the development of IHD were also examined. None of these risk factors
alone, with the exception of age and chronic pyelonephritis, were found
to contribute significantly to the incidence of dialysis-acquired IHD.
When the joint contribution of these variables was analyzed using Cox
regression analysis, race and diastolic hypertension also were discov-
ered to contribute significantly to IHD. However, smoking and serum
triglycerides were not found to be significant risk factors. From these
data, it is concluded that older patients are a greater risk than younger
patients, that white patients are at a greater risk than black patients,
that patients with elevated diastolic blood pressure are at an increased
risk and that patients with chronic pyelonephritis as the underlying
renal disease are at an increased risk.
Relation entre les facteurs de risque coronarien a cardiopathies ischem-
iques au cours associé avec hemodialyses. Les dossiers de 320 malades
hémodialysCs risquant de developper une cardiopathe ischCmique
(IHD) aient été examine afin de determiner l'influence des facteurs de
risque connus, pression artérielle, tabagisme, triglycerides seriques et
age sur l'incidence de IHD et de développer des profils de risque
coronarien pour Ia population des hémodialyses. Le role du volume des
globules rouges, de Ia race, du sexe, ct de Ia cause de l'insuffisance
rénale dans le dCveloppement de l'IHD aient été examine aussi. Aucun
de ces facteurs de risque en soi, a l'exception de l'ãge et de Ia
pyelonephrite chronique, aient été trouvC contribuer significativement a
l'incidence de l'THD acquise lors de La dialyse. Lorsque Ia contribution
conjointe de ces variables a été analysée par regression de Cox, Ia race
et l'hypertension diastolique se sont Cgalement révélées contribuer
significativement a l'IHD. En revanche, Ic tabagisme et les triglycerides
sériques ne sont pas apparus comme étant des facteurs de risque
significatifs. Dc ces donnCes ii aie été conclu que les malades plus ages
ont un plus grand risque que les plus jeunes, que les malades blancs ont
un plus grand risque que les noirs, que les malades ayant une pression
artCrielle diastolique élevée ont un risque accru, et que les malades
ayant une pyélonephrite chronique comme nephropathie sous-jacente
ont un risque augmenté.
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Patients with endstage renal disease undergoing maintenance
hemodialysis have an increased prevalence of conventional
coronary risk factors [1—41. This observation, together with a
high cardiovascular mortality, has led to the view that hemodi-
alysis patients have an accelerated rate of atherosclerosis and
an increased mortality from coronary artery disease [51. While
the concept of accelerated atherosclerosis and accelerated
coronary mortality in this population has been questioned by
several investigators including ourselves [6—91, there is agree-
ment that coronary risk factors, especially hypertriglyceride-
mia, hypertension and left ventricular hypertrophy (LVH), are
present with increased frequency. However, few detailed stud-
ies have been carried out to examine whether these or other risk
factors indeed are associated significantly with the development
of dialysis-related ischemic heart disease (IHD). Two studies of
the Seattle dialysis population have shown an association
between smoking and hypertension and mortality of all causes,
including stroke and myocardial infarction 110], and an associa-
tion between hypertriglyceridemia and cardiovascular events
[11]. Since these studies did not exclude patients with pre-
existing ischemic cardiovascular disease and because of the
inordinately high death rates from myocardial infarction when
compared to other published reports [9, 12], these demonstrat-
ed associations truly may not reflect a relationship between
conventional risk factors and presumed increased coronary risk
following the initiation of hemodialysis. In another study,
Vincenti et al [13] found an association between hypertension
and hemodialysis-associated atherosclerosis. However, the im-
portance of this single variable in the development of dialysis-
related atherosclerosis may be questioned since no age adjust-
ments were made in this study population in which the most
severe atherosclerotic disease was found in patients who were
more than a decade older than those with either minimal or
moderate disease.
Previously, we examined the incidence of IHD and the
prevalence of conventional coronary risk factors in a large
hemodialysis population. In this study, we evaluate the associa-
tion of established coronary risk factors and some additional
factors with the development of IHD in a hemodialysis popula-
tion to investigate the relative influence of these factors on
coronary risk and to develop a coronary risk profile fo: our
hemodialysis population.
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Table 1. Causes of endstage in hemodialysis population of The
University of Alabama Medical Center
Cause
Unknown
Glomerulonephritis
Malignant
hypertension
Polycystic kidney
disease
Pyelonephritis
Interstitial nephritis
Diabetic nephropathy
Obstructive
nephropathy
Miscellaneous'
Total 382 /00.0
a These include: myeloma kidney, 5; hereditary nephritis, 5; cortical
necrosis, 3; medullary cystic disease, 2; amyloidosis, 5; renal cell
carcinoma, I; renovascular disease, 2; and hypoplasia, I.
Methods
We reviewed the records of 382 patients who entered the
maintenance hemodialysis program at The University of Ala-
bama in Birmingham and at the Birmingham Veterans Adminis-
tration Medical Center between January 1971 and December
1975. These patients were followed for intervals up to 7 years
(January 1971 to January 1978). The mean duration of this
follow-up was 29.5 months (median, 28 months; range, 1 to 84
months). The characteristics of this group and the criteria for
acceptance into our hemodialysis program have been described
previously [9]. Of the 382 patients entering the maintenance
hemodialysis program during this time, 320 patients had no
evidence for ischemic heart disease prior lo the onset of
hemodialysis. These patients constituted the population at risk
and were the basis for our analysis. The mean age of this study
population was 42.2 SD 16.1 (age range, 6 to 79 years). There
were 165 women and 155 men. The group was divided almost
evenly between blacks and whites (164 vs. 156, respectively).
Table 1 shows the distribution of diseases causing endstage
renal disease in our population. Glomerulonephritis was diag-
nosed if it was documented by renal biopsy, if the patient had a
systemic disease often associated with glomerulonephritis, or if
urinalysis and urinary electrolyte and protein excretion suggest-
ed this diagnosis. Malignant hypertension was diagnosed if the
patient had diastolic blood pressures greater than 130 mm Hg in
association with grades 3 or 4 hypertensive retinopathy but in
the absence of any evidence for other causes of renal disease.
Polycystic kidney disease was diagnosed by physical examina-
tion, family history, and x-ray. Pyelonephritis was said to be
present in patients with chronically infected urine in the ab-
sence of other causes of renal disease. Interstitial nephritis was
said to be present if the patient had a history of analgesic
overuse, long-term exposure to lead, usually in the form of
moonshine whiskey, or recurrent stone passage. Objective
evidence of interstitial nephritis and pyelonephritis included x-
ray evidence of papillary necrosis or asymmetrically shrunken
kidneys. The presence of hyperchloremic acidosis and urinary
concentrating defects were considered as functional parameters
for this diagnosis. Diabetic nephropathy was diagnosed as
progressive renal failure in a patient with diabetes mellitus and
evidence of diabetic retinopathy but in the absence of other
causes of renal disease. Obstructive uropathy was diagnosed in
patients with a history of obstructive symptoms, stones, and x-
ray evidence of reflux or hydronephrosis. If no diagnosis could
17.0 be established, the patient was placed in the category of
unknown disease.
8.3 IHD was diagnosed when typical signs and symptoms of
4.0
angina pectoris or myocardial infarction occurred. The diagno-
3:0 sis of myocardial infarction was confirmed by serial electrocar-
diographic (ECG) QRST changes, by enzyme changes, or, as in
4.2 one instance, by autopsy. The clinical, laboratory, and ECG
6.2 criteria used to make the diagnosis of IHD were reviewed in
detail by Logue and Hurst [141. LVH was diagnosed using the
Estes ECG criteria [151. Fasting plasma triglyceride concentra-
tions were obtained during the first month of hemodialysis and
were determined by standard laboratory techniques. Age-relat-
ed normal values were similar to those described by Frederick-
son, Levy, and Lees [16]. Initial blood pressure represents that
pressure measured prior to the first hemodialysis. Dialysis
blood pressure represents the average blood pressure recorded
prior to each dialysis treatment during the course of hemodialy-
sis. A patient was considered to have a positive smoking history
if ten or more cigarettes were smoked per day. Pipe smoking,
cigar smoking, tobacco chewing, and snuff usage occurred
infrequently and, therefore, were not included in the consider-
ation of tobacco use.
An investigation was made into the possible joint contribu-
tions of the variables recorded for these patients to the probabil-
ity of acquiring IHD. To do this, we used the method of Cox
regression analysis. The Cox regression technique is a method
of survival analysis which investigates the simultaneous explan-
atory power of a number of independent variables in predicting
the likelihood of survival or occurrence of an event [17]. One or
more such explanatory variables are assumed to be available for
each individual in the analysis. The assumption of the Cox
model is that the hazard function is a function of a linear
combination of the explanatory variables, each weighted by
unknown regression coefficients. This function, in turn, may be
multiplied by an arbitrary or unknown function of time. Using
these assumptions, a partial likelihood function is formed and
an estimation of the coefficients is achieved by the method of
maximum likelihood. Once the parameters are estimated, the
relative risk may be calculated for factors considered in the
overall risk or hazard and may be generated for any particular
situation with respect to prognosis. The statistical procedure
used in the analysis was implemented by Frank E. Harrell, Jr.,
of Duke University. It is a FORTRAN procedure (PHGLM)
written for inclusion in the Statistical Analysis System (SAS)
and contains algorithms for straight Cox regression, for forward
stepwise Cox regression, and for backward elimination Cox
regression. The Breslow modification was used for tied data
[181. The backward elimination method was chosen as best able
to handle interactions among the variables when they were
present. Because care had to be taken that no higher order
interaction was retained with related lower order interactions or
with main effects deleted, this backward elimination method
was implemented in a 'hands on" manner.
Percent
31.0
21.7
Number
118
83
65
32
15
17
12
16
24
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Plasma
triglyceride
concentration
LVH,% mg/dI
41.9 173.1 89.0 43.3
(N—27) (N=30)
between groups 1 and 2 with respect to the presence of LVH,
history of smoking, or dialysis blood pressure. Group 1 had a
mean initial systolic blood pressure that was 7.5 mm Hg greater
SEM p than in group 2. A higher triglyceride concentration (28.8 mg/dl)
0 126 0 0117 was also noted in group 1.
0001 <0.0241 Multivariable analyses. The proportional hazards or Cox
0.380 <0.0786 regression model was used to investigate the relative contribu-
tions of the variables mentioned above to the risk for develop-
0.008 <0.0185 ing IHD in this set of dialysis patients. For the preliminary
0.494 <0.035() analysis a "full" model was used which yielded a likelihood
ratio test statistic of 323.3, which was significant at the 0.01%
level. This "full" model included the following effects: linear
age (P = 0.0077), age squared (P = 0.0120), race (P — 0.4000),
sex (P = 0.3535), race by sex (P = 0.3444), linear age by race (P
= 0.5894), linear age by sex (P — 0.4336), linear age by race and
sex (P = 0.3775), chronic pyelonephritis (P = 0.0392), malig-
nant hypertension (P — 0.1488), initial systolic blood pressure
(P = 0.9011), initial diastolic blood pressure (0.1674), triglycer-
ides (P = 0.1719), packed cell volume (P = 0.2592), and
smoking (P — 0.2192). Because of the high correlations which
would be expected among such variables as systolic and
diastolic blood pressure and the age, race, and sex variables
with their interactions, a stepwise procedure was used to
eliminate extraneous variables and to expose which of the total
variables listed were important for assessing risk for IHD. The
reduced model would be expected to be more easily interpret-
able and more stable. The regression coefficients, their standard
errors, and their P-values appear in Table 3. The significant
effects were linear age (P — 0.0117), squared age (P — 0.0241),
race (P = 0.0786), initial diastolic blood pressure (P = 0.0185),
and the presence of chronic pyelonephritis (P = 0.0350). A
summary of relative risks for selected values of these variables
is found in Table 4. According to this summary, older patients
would be at a greater risk for IHD than younger patients,
although there was a slight curvature in the age relationship in
the higher end of the age range which would place a 60-year-old
Sex, %
Group5 N Male Female
Table 2. Coronary risk factors in population at risk for developing ischemic heart disease (IHD) following the onset of hemodialysisa
Race,Age —
yrs Black White
Initial BP Dialysis BP
mm Hg m,n Hg
1 31 32.3 67.7
2 160 46.9 53.1
3 8 50.0 50.0
4 123 52.8 47.2
49.1 9.9 41.9 58.1 173.2 26.8
99.5 20.2
42.9 14.5 55.6 44.4 165.7 32.9
98.8 22.5
(N — 158)
Smoking
%
146.0 + 20.5
82.5 11.4
(N = 29)
147.2 18.8
84.3 10.6
(N — 138)
46.8
(N 156)
144.3 65.9 45.2
(A' = 135) (N = 155)
40.4 8.8 25.0 75.0 177.5 41.6 146.4 + 11.7
113.8 27.8 84.0 5.5
37.7 15.3 50.4 49.6 166.7 33.9 150.0 21.9 38.8
100.9 22.7 85.3 10.3 tN — 121)
(N=49)
75.0 154.6 98.5 7.0
(N -7)
140.8 71.8
(N = 41)
42.6
(N— 115)
Values are mean SD except for sex, race. LVH, and smoking, which are percentages. LVH is left ventricular hypertrophy. Numbers in
parentheses represent sample size when data were only available fir a subset of the whole group.
Groups: I, patients who developed IHD in 2 years or less; 2, patients followed for more than 2 years with no IHD; 3, patients who developed
IHD after 2 years; 4, patients followed 2 years or less with no IHD.
Table 3. Variables contributing significantly to risk of ischemic heart
disease'
Variables'
Age
Age squared
Race
Initial diastolic blood
pressure
Chronic pyelonephritis
Regression
coefficient
0.3 19
—0.003
0.668
0.019
1.040
Analysis by Cox regression model.h Variables not included in the final model were: Sex (P — 0.90);
linear age x race (P = 0.96); linear age x sex (P — 0.97); race x sex (P
= 0.87); linear age x race x sex (P — 0.93); systolic initial blood
pressure (P = 0.83); smoking (P — 0.35); packed cell volume (P = 0.59):
malignant hypertension (P — 0.23); serum triglycerides (P = 0.25).
Results
Coronary risk frictors in patients undergoing hemodialysis
who were at risk .for developing ischemic heart disease. The
patients at risk for ischemic heart disease were placed in four
groups (Table 2). The first group contains those patients who
developed IHD within a 2-year period following the onset of
hemodialysis. Group 2 contains those patients who were fol-
lowed for at least a 2-year period and showed no signs of IHD.
Group 3 represents patients who developed IHD anytime after
the initial 2-year period. The group 4 patients had follow-up
times less than or equal to 2 years but did not have IHD during
this follow-up period. For purposes of describing a group
developing IHD and a group without symptomatic IHD, groups
1 and 2 are the most comparable. As shown in Table 2, group I
has more female patients than group 2 (67.7°% compared to
53.1%). Group I patients were about 6.2 years older than group
2 patients and had a higher percentage of white patients (58.1%
compared to 44.4%). No group differences were apparent
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analytic method could not distinguish sex as a statistically
significant risk factor. Nevertheless, sex must be considered a
clinically important risk factor because rates of IHD in women
— Risk have not been found generally to equal or exceed those of men
ratio until age 68 years [19].
2.9741 Our findings underscore the importance of hypertension in
4.8547 the development of IHD in the hemodialysis population and are
4.3491 in agreement with those of Haire et al [101. We also concur with
9O4 Vincenti et a! [131 that rigorous control of hypertension in theincipient stages of renal failure may significantly reduce the
frequency of IHD developing after the onset of hemodialysis.
2.8303 Our rather surprising finding that the average blood pressure on
dialysis which was significantly lower than the initial (pre-
dialysis) blood pressure (Table 1) appeared not to influence
2.1299 coronary risk either favorably or unfavorably also supports
3.1083 observations of Vincenti et al [131 who found an equal percent-
age of hypertensive dialysis patients among those with the
mildest and most severe degrees of atherosclerosis.
The positive association between serum triglyceride concen-
tration and coronary artery disease which has been noted in
nondialysis patients [201 and also reported for Seattle dialysis
patients [11] was not found in our population. This observation
is in accord with the analysis of Somer et al [211 which
suggested that the lipid disorders found in chronic renal failure
may not be important factors in the atherogenic process. The
lack of association between serum triglyceride concentration
and risk for IHD in our patient population, however, should not
be construed to mean that all abnormalities of lipid metabolism,
found with high prevalence in patients undergoing hemodialy-
sis, are unimportant since we did not measure other indices of
altered lipid metabolism such as increased levels of low density
lipoprotein (LDL) or reduced levels of high density lipoprotein
(HDL). In this regard also, we have reported previously that
women had the highest elevations of serum triglyceride which
may have contributed to their accelerated rate of IHD [9]. This
concept is strengthened by the studies of Heyden et al [22] who
found serum triglyceride concentrations to be predictive of IHD
in women but not in men.
Smoking did not contribute significantly to coronary risk in
our population unlike the Seattle study [101. While smokers
have been noted to have more intense changes of coronary
atherosclerosis in the nondialysis patient population than non-
smokers, there is no agreement regarding the association of
smoking in either myocardial infarction or angina pectoris [23].
The conflicting data regarding the relative importance of
coronary risk factors in the Seattle dialysis population and in
our own group of patients may be explained in several ways.
First, differences in the racial composition of our population
may be important for there were more blacks in our study
population than in the Seattle group. Second, the two Seattle
studies did not exclude patients with pre-existent IHD. Third,
the endpoints examined were different for each study popula-
tion. In the Seattle studies, death from myocardial infarction
and stroke or the development of any cardiovascular event was
used whereas in our studies the development of symptomatic
IHD (myocardial infarction or angina pectrois) was used as the
endpoint. We recognize that the endpoint we have chosen may
represent a small overestimate of the incidence of atheroscle-
rotic heart disease since symptomatic IHD can occur in the
absence of all evidence of coronary atherosclerosis [24]. Thus,
Relative risk
Favorable
0.5760 (30)
Factor
Age
Race
Chronic
pyelonephritis
Diastolic
Initial BP
0.7235 (B)
0.9527 (—)
0.6845 (80)
41. 43 17)
— 1931.6739)
0.4845)
Table 4. Relative risk of acquiring ischemic heart disease in
hemodialysis patients as a function of risk factor
Unfavorable
1.7131 (40)
2.7963 (50)
2.5051 (60)
1.4111 (W)
2.6964 (+)
1.4579 (120)
2.1276 (140)
Log. (H(t)/H0(t)) = 0.3 190 (Age —
—0.0030 (Age2
+0.6680 (Race
+1.0404 (Chronic pyelonephritis — 0.0466)
+0.0189 (Diastolic initial BP 100.0531)
where H(t)/H0(t) is the relative risk for the ith observation by the Cox
regression model. Coding used in these models are: race (black, 0;
white, 1); male, 0; female, I; specific disease (absent, 0; present. I).
Symbols: Numbers in parentheses represent age or diastolic pres-
sure; letters in parentheses represent race; ( ), absent; (+), present.
patient at a little less risk than a 50-year-old patient even though
both would be at much greater risk than a 30-year-old patient.
White patients were at greater risk than black patients for IHD.
Patients who had chronic pyelonephritis as the underlying renal
disease were at increased risk compared to those with other
diseases. Lastly, patients with higher levels of initial diastolic
blood pressure were at greater risk than those with lower levels.
The relative risk for a patient with any given profile can be
estimated using the function provided at the bottom of Table 4.
This study demonstrates that, by using the method of Cox
regression analysis, we were able to define a group of factors
which was associated significantly with an increased risk for
developing IHD during hemodialysis therapy. These factors
were linear age, age squared, race, and initial diastolic blood
pressure. Surprisingly, we also found that the presence of
chronic pyelonephritis as the underlying renal disease appeared
as a risk factor for the development of IHD. Older patients in
general were at a greater risk for IHD than younger patients.
The risk ratio was 2.97 for a 40-year-old patient compared to a
30-year-old patient and 4.85 for a 50-year-old patient compared
to a 30-year-old patient. The relative risk for a white patient
compared to a black patient was almost twice as great (1.95). If
chronic pyelonephritis was the precipitating cause of renal
failure, the relative risk, holding other factors constant, was
2.83. Patients with initial diastolic blood pressures around 120
mm Hg had a relative risk of 2.13 compared with patients whose
diastolic blood pressures were around 80 mm Hg. If the initial
diastolic blood pressures were as high as 140 mm Hg, the risk
for IHD was three times as great as it would have been with
diastolic blood pressures of 80 mm Hg. Because the number of
men and women developing IHD were about the same, this
Discussion
308 Rosiand et al
the absence of standardized endpoints and differences in the
composition of the study populations underscore some of the
difficulties in interpreting data from different epidemiologic
studies.
An important implication of this study is that many of the
factors which we have shown to be associated strongly with
coronary risk do not appear to be readily controllable by the
physician. Of these factors, race, age, sex, and the underlying
cause of renal failure and hypertension, only hypertension that
exists prior to the onset of dialysis therapy seems amenable to
correction since the level of blood pressure on dialysis did not
affect coronary risk favorably or unfavorably. These observa-
tions, coupled with the finding that most new IHD events
occurred in older patients within the first year of treatment [9],
suggest that variables present prior to the onset of hemodialysis
may contribute significantly to coronary risk and that the
atherosclerotic process may be well into its course when
dialysis is initiated. In this regard, there may be other factors
not considered in this study, such as the duration of renal
disease prior to the onset of dialysis [25] and factors which are
associated with this variable that may contribute to dialysis
coronary risk.
In conclusion, the data from these studies show that irrespec-
tive of whether or not one believes that the rates of IHD are
accelerated in the hemodialysis population, several important
risk factors for the development of IHD in this population have
been defined. These include diastolic hypertension existing
prior to the onset of dialysis, race, age, and sex. The presence
of chronic pyelonephritis as a cause of endstage renal disease
also appeared as a significant risk factor for unexplained
reasons. In our population, smoking and triglyercide concentra-
tions were not significantly associated with risk for IHD despite
their increased prevalence in the dialysis population.
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